Access cutting-edge bladder cancer treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access bladder cancer specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bladder cancer treatment provided free
The purpose of this study is to compare disease free survival (DFS) in participants with recurrence of papillary-only high-risk non-muscle-invasive bladder cancer (HR-NMIBC) within 1 year of last dose of Bacillus Calmette-Guérin (BCG) therapy and who refused or are unfit for Radical Cystectomy (RC), receiving TAR-200 versus investigator's choice of single agent intravesical chemotherapy.
Sponsor: Janssen Research & Development, LLC
Check if you qualify for this bladder cancer clinical trial in Chicago, IL
If you're searching for bladder cancer treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.